Nanopath

Nanopath is a molecular diagnostics company disrupting traditional testing methods. Its goal is to improve women's health by providing fine-grained and clinically actionable information in a single office visit. Nanopath is committed to improving global health equity, starting with women's health. Nanopath’s proprietary molecular diagnostic tests employ a novel approach to measuring and characterizing human health. Through its innovative biosensing technology, the company has the potential to perform rapid, high-complexity tests at the point of care within minutes, rather than in centralized laboratories. The founders of Nanopath aim to enhance the lives of women and other underserved populations while also improving the lives of Nanopath team members through purpose-driven work that contributes to the development and deployment of their products.